Immunoblockade of endogenous glucagon-like peptide-1 by monoclonal antibodies in conscious rats: Effect on the insulin response to intragastric glucose

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 41-46

  Van Delft, Jozef ^b   Uttenthal, Otto ^b   Koch, Claus ^b   Ghiglione, Margarita ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IMMUNOREGULATION; INSULIN RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 0032946892     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90008-2     Document Type: Article

References (30)

1. Kreymann B, Williams G, Ghatei MA, et al: Glucagon-like peptide-1 (7-36): A physiological incretin in man. Lancet 2:1300-1304, 1987
2. Herrmann C, Göke R, Richter G, et al: Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56:117-126, 1995
3. Herrmann-Rinke C, Voge A, Hess M, et al: Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol 147:25-31, 1995
4. Dumoulin V, Dakka T, Plaisancie P, et al: Regulation of glucagon-like peptide-1-(7-36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Endocrinology 136:5182-5188, 1995
5. Brubaker PL: Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128:3175-3182, 1991
6. Mojsov S, Weir GC, Habener JF: Insulinotropin: Glucagon-like peptide 1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619, 1987
7. Holst JJ, Ørskov C, Nielsen OV, et al: Truncated glucagon-like peptide 1, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174, 1987
8. Weir GC, Mojsov S, Hendrick GK, et al: Glucagonlike peptide 1 (7-37) actions on endocrine pancreas. Diabetes 38:338-342, 1989
9. Göke R, Fehmann H-C, Linn T, et al: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268:19650-19655, 1993
10. Kolligs F, Fehmann HC, Göke R, et al: Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19, 1995
11. Valverde I, Morales M, Clemente F, et al: Glucagon-like peptide 1: A potent glycogenic hormone. FEBS Lett 349:313-316, 1994
12. Ruiz-Grande C, Alarcón C, Mérida E, et al: Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 13:13-16, 1992
13. Suzuki S, Kawai K, Ohashi S, et al: Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Endocrinology 125:3109-3114, 1989
14. Gefel D, Hendrick GK, Mojsov S, et al: Glucagon-like peptide-1 analogs: Effects on insulin secretion and adenosine 3′,5′-monophosphate formation. Endocrinology 126:2164-2168, 1990
15. van Delft J, Uttenthal LO, García-Hermida O, et al: Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay. Regul Pept 70:191-198, 1997
16. Varndell IM, Bishop AE, Sikri KL, et al: Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 33:1080-1086, 1985
17. Suda K, Takahashi H, Fukase N, et al: Distribution and molecular forms of glucagon-like peptide in the dog. Life Sci 45:1793-1798, 1989
18. Namba M, Itoh H, Watanabe N, et al: Multiple forms of glucagon-like peptide-1 and glucagon-like immunoreactivities in canine gastrointestinal tract and their release into circulation. Biomed Res 11:247-254, 1990
19. Eissele R, Göke R, Willemer S, et al: Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22:283-291, 1992
20. Abello J, Ye F, Bosshard A, et al: Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line. Endocrinology 134:2011-2017, 1994
21. Gill SS, Lee YC, Ghatei MA, et al: The use of a rat isolated ileal preparation to investigate the release of neurotensin. Clin Exp Pharmacol Physiol 11:457-466, 1984
22. Plaisancie P, Bernard C, Chayvialle JA, et al: Regulation of glucagon-like peptide-1-(7-36)amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon. Endocrinology 135:2398-2403, 1994
23. Roberge JN, Brubaker PL: Regulation of intestinal proglucagon derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240, 1993
24. Roberge JN, Gronau KA, Brubaker PL: Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut. Endocrinology 137:2383-2388, 1996
25. Buchan AM, Polak JM, Capella C, et al: Electron immunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56:37-44, 1978
26. Siddle K: Properties and applications of monoclonal antibodies, in Collins WP (ed): Alternative Immunoassays. New York, NY, Wiley, 1985, pp 13-37
27. D'Alessio DA, Prigeon RL, Ensinck JW: Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide 1. Diabetes 44:1433-1437, 1995
28. Scrocchi LA, Brown TJ, MacLusky N, et al: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258, 1996
29. Cheeseman CI, Tsang R: The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. Am J Physiol 271:G477-G482, 1996
30. Jia X, Brown JC, Ma P, et al: Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. Am J Physiol 268:E645-E651, 1995